SAB Biotherapeutics
SABS
SABS
38 hedge funds and large institutions have $2.42M invested in SAB Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 8 closing their positions.
Holders
38
Holders Change
-2
Holders Change %
-5%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
